© 2023 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2023 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
CONNORS CLINIC PHARMACY
PO BOX 9
June 01, 2016
A network meta-analysis compared GLP-1 receptor agonists to traditional anti-diabetes drugs based on hypoglycemia incidence, HbA1c goals, and more.
May 31, 2016
Researchers compared the safety and efficacy of a GLP-1 receptor agonist in patients aged 65 years or older to those under 65 years.
May 06, 2016
Does the body mass index of a diabetic patient have any effect on the efficacy of GLP-1 receptor agonists?
May 05, 2016
Can adding a GLP-1 receptor agonist to lifestyle changes improve obstructive sleep apnea management in your patients?
March 31, 2016
Clinical trials have shown that GLP-1 RAs reduce HbA1c and weight in type 2 diabetes, but are these outcomes confounded by concomitant medications?
March 30, 2016
A meta-analysis examined the effect of treatment with a GLP-1 receptor agonist on cardiovascular event risk in type 2 diabetes patients.